325 related articles for article (PubMed ID: 29514903)
21. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
Ma Z; Hopcraft SE; Yang F; Petrucelli A; Guo H; Ting JP; Dittmer DP; Damania B
PLoS Pathog; 2017 May; 13(5):e1006350. PubMed ID: 28459883
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
Cheng F; He M; Jung JU; Lu C; Gao SJ
J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
[TBL] [Abstract][Full Text] [Related]
23. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
Bi X; Yang L; Mancl ME; Barnes BJ
J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.
Joo CH; Shin YC; Gack M; Wu L; Levy D; Jung JU
J Virol; 2007 Aug; 81(15):8282-92. PubMed ID: 17522209
[TBL] [Abstract][Full Text] [Related]
25. Rhesus Macaque Rhadinovirus Encodes a Viral Interferon Regulatory Factor To Disrupt Promyelocytic Leukemia Nuclear Bodies and Antagonize Type I Interferon Signaling.
Springgay LK; Fitzpatrick K; Park B; Estep RD; Wong SW
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626678
[TBL] [Abstract][Full Text] [Related]
26. Shiftless Restricts Viral Gene Expression and Influences RNA Granule Formation during Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Rodriguez W; Mehrmann T; Hatfield D; Muller M
J Virol; 2022 Nov; 96(22):e0146922. PubMed ID: 36326276
[TBL] [Abstract][Full Text] [Related]
27. NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target.
Hughes DJ; Wood JJ; Jackson BR; Baquero-Pérez B; Whitehouse A
PLoS Pathog; 2015 Mar; 11(3):e1004771. PubMed ID: 25794275
[TBL] [Abstract][Full Text] [Related]
28. DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi's Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs.
Serfecz JC; Hong Y; Gay LA; Shekhar R; Turner PC; Renne R
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298642
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-κB signaling pathways.
Zhu X; Zhou F; Qin D; Zeng Y; Lv Z; Yao S; Lu C
J Mol Biol; 2011 Jul; 410(5):1035-51. PubMed ID: 21763505
[TBL] [Abstract][Full Text] [Related]
30. Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication.
Park MK; Cho H; Roh SW; Kim SJ; Myoung J
Sci Rep; 2019 Feb; 9(1):2372. PubMed ID: 30787356
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.
Jacobs SR; Stopford CM; West JA; Bennett CL; Giffin L; Damania B
J Virol; 2015 Nov; 89(22):11572-83. PubMed ID: 26355087
[TBL] [Abstract][Full Text] [Related]
32. ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway.
Zhang H; Ni G; Damania B
Cell Rep; 2020 Apr; 31(4):107564. PubMed ID: 32348766
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
34. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.
Qin D; Feng N; Fan W; Ma X; Yan Q; Lv Z; Zeng Y; Zhu J; Lu C
BMC Microbiol; 2011 Oct; 11():240. PubMed ID: 22032493
[TBL] [Abstract][Full Text] [Related]
35. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.
Liang D; Gao Y; Lin X; He Z; Zhao Q; Deng Q; Lan K
Cell Res; 2011 May; 21(5):793-806. PubMed ID: 21221132
[TBL] [Abstract][Full Text] [Related]
36. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.
Avey D; Tepper S; Pifer B; Bahga A; Williams H; Gillen J; Li W; Ogden S; Zhu F
J Virol; 2016 Jul; 90(13):5953-5964. PubMed ID: 27099309
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
Yang M; Huang L; Li X; Kuang E
Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
[TBL] [Abstract][Full Text] [Related]
39. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
40. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
